Activin and Inhibin

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.In VivoImirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in

Imlunestrant (LY-3484356) is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant

Imlunestrant (LY-3484356) is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant

Imlunestrant (LY-3484356) tosylate is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant tosylate results in sustained inhibition of ER-dependent gene transcription and cell

Imlunestrant (LY-3484356) tosylate is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant tosylate results in sustained inhibition of ER-dependent gene transcription and cell

Imoxiterol (RP 58802B) is a β-adrenergic agonist.Form:SolidIC50&amp: Target:β-adrenergic.

IMP-1088 is a potent human N-myristoyltransferases NMT1 and NMT2 dual inhibitor with IC 50 s of &lt:1 nM for HsNMT1 and HsNMT2. IMP-1088 has a K d of &lt:210 pM for HsNMT1. IMP-1088 efficiently blocks rhinovirus replication by blocking rhinovirus